DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 081267
The generic ingredient in METHYLPREDNISOLONE SODIUM SUCCINATE is methylprednisolone sodium succinate. There are forty drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the methylprednisolone sodium succinate profile page.
Summary for 081267
Tradename: | METHYLPREDNISOLONE SODIUM SUCCINATE |
Applicant: | Teva Parenteral |
Ingredient: | methylprednisolone sodium succinate |
Patents: | 0 |
Therapeutic Class: | Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal) Inflammatory Bowel Disease Agents |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 500MG BASE/VIAL | ||||
Approval Date: | Nov 30, 1992 | TE: | RLD: | No |
Complete Access Available with Subscription